Kaye Spratt

Kaye Spratt has an extensive background in regulatory affairs and quality management, with significant experience in leadership roles within the biotechnology industry. Kaye has held positions such as Senior Vice President at Rejuvenate Bio, Chief Regulatory Officer at BridgeBio Gene Therapy, and Vice President at Abeona Therapeutics, Inc. Their career also includes roles at BridgeBio and Sangamo, demonstrating a strong track record of success in regulatory and quality management throughout their career.

From 1974 to 1979, Kaye Spratt attended Meharry Medical College, where they studied Microbiology.